Skip to content

Lumexa Imaging Holdings, Inc. LMRI Additional Paid-In Capital

Additional Paid-In Capital at other companies

Lantheus Holdings logo
Lantheus HoldingsLNTH
$892.95M+8.7%
Boston Scientific logo
Boston ScientificBSX
$21.58B+2.2%
Novanta logo
NovantaNOVT
$556.41M+609%
Labcorp Holdings logo
Labcorp HoldingsLH
Quest Diagnostics logo
Quest DiagnosticsDGX

Other financials

Income statement

See full
Revenue$252.5M+3.1%
Operating income$19.4M-24.0%
Net income$1.7M+122%
EPS (diluted)$0.02+118%

Balance sheet

See full
Cash & equivalents$51.2M
Total debt$965.8M
Total equity$599.6M+272%
Total assets$1.8B

Cash flow

See full
Operating cash flow$2.9M+121%
CapEx$5.3M+431%
Free cash flow-$2.4M+84.1%

Valuation

See full
Market cap$1.02B-42.0%
Enterprise value$1.93B

Returns & leverage

See full
Debt / equity1.6×
Current ratio1.4×

Where this comes from

Reported directly by Lumexa Imaging Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Lumexa Imaging Holdings, Inc. ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lumexa Imaging Holdings, Inc. 's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lumexa Imaging Holdings, Inc. 's additional paid-in capital?
Lumexa Imaging Holdings, Inc. (LMRI) reported additional paid-in capital of $1.23B in Q1 2026.
What does additional paid-in capital mean?
This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.